|
業務類別
|
Biotechnology |
|
業務概覽
|
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development. |
| 公司地址
| 825 Industrial Road, Suite 300, San Carlos, CA, USA, 94070 |
| 電話號碼
| +1 650 837-0111 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.vaxcyte.com |
| 員工數量
| 507 |
| Mr. Andrew L. Guggenhime, M.B.A. |
Chief Financial Officer and President |
美元 620.00K |
23/04/2026 |
| Mr. Grant E. Pickering |
Director and Chief Executive Officer |
美元 800.00K |
23/04/2026 |
| Mr. David R. McAvoy |
Chief Legal Officer, Chief Compliance Officer and Secretary |
-- |
03/09/2026 |
| Mr. Jim Wassil |
Executive Vice President and Chief Operating Officer |
美元 600.00K |
23/04/2026 |
| Mr. Harp Dhaliwal |
Chief Technical Operations Officer |
美元 495.00K |
23/04/2026 |
| Mr. Mikhail Eydelman |
Senior Vice President and General Counsel |
美元 501.00K |
03/09/2026 |
| Ms. Elvia Cowan |
Senior Vice President, Finance and Principal Accounting Officer |
-- |
24/02/2026 |
|
|
| Dr. Carlos V. Paya,M.D.,PhD |
Chairman of the Board |
23/04/2026 |
| Dr. Moncef M. Slaoui, PhD |
Director |
23/06/2026 |
| Mr. Grant E. Pickering |
Director and Chief Executive Officer |
23/04/2026 |
| Dr. Olivier Raymond Brandicourt, M.D. |
Independent Director |
23/04/2026 |
| Ms. Halley E. Gilbert |
Independent Director |
23/04/2026 |
| Mr. John P. Furey |
Independent Director |
23/04/2026 |
| Ms. Annie Seibold Drapeau |
Independent Director |
23/04/2026 |
| Dr. John H. Markels, PhD |
Independent Director |
15/07/2026 |
| Ms. Teri Loxam, M.B.A. |
Independent Director |
23/04/2026 |
|
|
|
|
